Featured Image

FDA has Authorized Pfizer-BioNTech COVID-19 Vaccine for Kids 5 to 11

The Food and Drug Administration (FDA) authorized the use of the Pfizer-BioNTech pediatric COVID-19 vaccine for 5 to 11 years old. The agency said that the decision was based on data from a clinical trial showing that this lower-dose vaccine was 90.7 percent effective for preventing the COVID-19 in this age group. In addition, no…